US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi U.S. Biotech 2x Daily ETF

31.94

0.0000

Volume:32

Turnover:1.07K

Market Cap:958.25K

PE:- -

High:31.94

Open:31.94

Low:31.94

Close:31.94

52wk High:42.22

52wk Low:25.26

Shares:30.00K

Float Shares:30.00K

Volume Ratio:0.01

T/O Rate:0.11%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why

Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes

Arecor to Present Half-Year Results as It Advances Next-Generation Diabetes Therapies

Biotech IPOs Charge Ahead as Tech Deals Stall

3 Australian Biotech Stocks With At Least 64% Fair Value Upside

Simply Wall St.

Why is Alector Stock (ALEC) 60% Higher Today?

Percheron Therapeutics Names New CEO to Drive Oncology Strategy and Investor Outreach

BICO folds Cellenion into SCIENION to sharpen precision biotech focus

Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase

Mizuho biotech analysts hold an analyst/industry conference call

JPMorgan SMid biotech analysts hold an analyst/industry conference call

RYUK-IL C&S pivots to biotech and pet markets with sweeping charter changes

Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”

3 Australian Biotech Stocks With Up To 77% Fair Value Upside

Simply Wall St.

New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector

Invivyd Phase 3 COVID Antibody Trial Shows Superior Safety

GT Biopharma Regains Nasdaq Minimum Bid Compliance

VOOLT boosts deeptech portfolio with discounted stake in cancer vaccine developer Vaxican

Arterra Bioscience Secures €2 Million Backing for NEX-BIO Biotech Expansion

Enlivex Drops RAIN-Token Financing Deal, Halts Planned Private Placement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/XBIX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","market":"US","secType":"STK","nameCN":"Corgi U.S. Biotech 2x Daily ETF","latestPrice":31.9418,"timestamp":1791573422212,"preClose":31.9418,"halted":0,"volume":32,"delay":0,"changeRate":0,"floatShares":30000,"shares":30000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"10-09 15:37:35 EDT","open":31.9418,"high":31.9418,"low":31.9418,"amount":1067.534304,"amplitude":0,"askPrice":33.84,"askSize":200,"bidPrice":33.75,"bidSize":200,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":31.9418,"nav":32.3,"aum":969000,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.82,"preClose":31.9418,"latestTime":"16:10 EDT","volume":7,"amount":223.1672,"timestamp":1791490204587,"change":-0.1218,"changeRate":-0.003813,"amplitude":0},"volumeRatio":0.006567},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","floatShares":30000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.006567,"shares":30000,"dividePrice":0,"high":31.9418,"amplitude":0,"preClose":31.9418,"low":31.9418,"week52Low":25.2639,"pbRate":"--","week52High":42.2188,"institutionHeld":0,"latestPrice":31.9418,"eps":0,"divideRate":0,"volume":32,"delay":0,"ttmEps":0,"open":31.9418,"prevYearClose":25.42,"prevWeekClose":34.2139,"prevMonthClose":35.9112,"prevQuarterClose":35.9112,"fiveDayClose":34.2139,"twentyDayClose":35.4698,"sixtyDayClose":34.5998},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBIX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBIX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBIX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674486678","title":"Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2674486678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674486678?lang=en_us&edition=fundamental","pubTime":"2026-10-10 02:12","pubTimestamp":1791569531,"startTime":"0","endTime":"0","summary":"Moderna shares ($MRNA) climbed by 13% to around $223 on Friday afternoon, pushing the U.S. biotech and pharma company past its one-year high of $21...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-stock-mrna-climbs-13-to-top-52-week-high-heres-why?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-stock-mrna-climbs-13-to-top-52-week-high-heres-why?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","GNOM","IDNA","BK4568","MRNY","BK4588","BK4533","WDNA","BK4534","LGHT","BK4139","MRNA","BK4532","BK4501","BK4548","XBIX","BK4551","MRNX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674184887","title":"Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes","url":"https://stock-news.laohu8.com/highlight/detail?id=2674184887","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674184887?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:52","pubTimestamp":1791514334,"startTime":"0","endTime":"0","summary":"Linical Co., Ltd. ( ($JP:2183) ) has issued an update. Linical Co., Ltd. has secured a large new order from a U.S. biotechnology company worth 20.4...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","JDOC","RSPH","PBE","BK4581","BBP","BK4588","IEIH","DARP","LNGR","XT","FHLC","IBB","FWD","SYNB","XBIX","AGNG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673072167","title":"Arecor to Present Half-Year Results as It Advances Next-Generation Diabetes Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2673072167","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673072167?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:04","pubTimestamp":1791461092,"startTime":"0","endTime":"0","summary":"Arecor Therapeutics PLC ( ($GB:AREC) ) has provided an announcement. Arecor Therapeutics plc, a Cambridge-based clinical-stage biotech, is developi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arecor-to-present-half-year-results-as-it-advances-next-generation-diabetes-therapies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arecor-to-present-half-year-results-as-it-advances-next-generation-diabetes-therapies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","XBIX","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673785620","title":"Biotech IPOs Charge Ahead as Tech Deals Stall","url":"https://stock-news.laohu8.com/highlight/detail?id=2673785620","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673785620?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:30","pubTimestamp":1791451800,"startTime":"0","endTime":"0","summary":"Biotechnology companies are sprinting to the public markets and defying a broader IPO slowdown.Twenty-three biotechs staged initial public offerings in the first three quarters this year, nearly tripl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK4588","REDS","BK4581","XBIX","BK4585","NVIB","FRHC","IPO","XBI","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011506","title":"3 Australian Biotech Stocks With At Least 64% Fair Value Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011506","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011506?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:48","pubTimestamp":1791373688,"startTime":"0","endTime":"0","summary":"IMF warnings about high public debt and the risks around rapid AI investment have pushed many investors to look for sectors where real science backs the story. Australian biotech stocks fit that brief, with businesses built around research pipelines rather than hype. For investors willing to handle higher risk, this corner of the market can be compelling. This article highlights three stocks from our biotech screen that may warrant closer examination.\nThe three biotech stocks below are only a...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-vls/vita-life-sciences-shares/news/3-australian-biotech-stocks-with-at-least-64-fair-value-upsi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-vls/vita-life-sciences-shares/news/3-australian-biotech-stocks-with-at-least-64-fair-value-upsi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","VAP.AU","VLS.AU","ZYAU.AU","XKO.AU","IMLC.AU","XJO.AU","BEAR.AU","QRE.AU","BK4581","BK7508","SLF.AU","QFN.AU","BBOZ.AU","OZF.AU","EIGA.AU","BK4585","IIGF.AU","IOZ.AU","DACE.AU","CUV.AU","BK4588","XBIX","BK7067","AIPO","BK7096","IISV.AU","STW.AU","XAO.AU","GEAR.AU","NVIB","MYX.AU","OZR.AU","E200.AU","GIVE.AU","VAS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673700156","title":"Why is Alector Stock (ALEC) 60% Higher Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673700156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673700156?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:18","pubTimestamp":1791206284,"startTime":"0","endTime":"0","summary":"Shares in U.S biotech firm Alector ($ALEC) surged 60% in pre-market trading today after Swiss drugmaker Roche ($RHHBY) agreed to pay up to $1.27 to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-alector-stock-alec-60-higher-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-alector-stock-alec-60-higher-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","ALEC","BK4139","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673768757","title":"Percheron Therapeutics Names New CEO to Drive Oncology Strategy and Investor Outreach","url":"https://stock-news.laohu8.com/highlight/detail?id=2673768757","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673768757?lang=en_us&edition=fundamental","pubTime":"2026-10-05 05:59","pubTimestamp":1791151185,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Percheron Therapeutics ( ($AU:PER) ). Percheron Therapeutics has appointed experienced biotech executive Dr Mic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-names-new-ceo-to-drive-oncology-strategy-and-investor-outreach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-names-new-ceo-to-drive-oncology-strategy-and-investor-outreach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","XBIX","NVIB","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672991794","title":"BICO folds Cellenion into SCIENION to sharpen precision biotech focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2672991794","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672991794?lang=en_us&edition=fundamental","pubTime":"2026-10-02 13:32","pubTimestamp":1790919176,"startTime":"0","endTime":"0","summary":"BICO Group AB Class B ( ($SE:BICO) ) has issued an announcement. BICO Group AB has completed the integration of single-cell specialist Cellenion in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bico-folds-cellenion-into-scienion-to-sharpen-precision-biotech-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bico-folds-cellenion-into-scienion-to-sharpen-precision-biotech-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0261945553.USD","LU0737861269.HKD","LU2008162690.USD","LU0516422952.EUR","LU1242518857.USD","SG9999002406.SGD","LU1861220207.SGD","SGXZ58947870.SGD","LU0589944569.HKD","LU2065171311.SGD","SG9999013478.USD","SG9999013460.SGD","XBIX","SG9999014484.SGD","LU0499858438.USD","NVIB","LU2177674079.SGD","LU2152927971.USD","BK4588","LU0289960550.SGD","LU0516422440.USD","BK4503","SE","BK4585","LU0210637038.USD","LU0072462343.USD","BK4551","LU0516423174.USD","SG9999006266.SGD","BK4220","LU0572940350.SGD","LU1861217088.USD","SG9999013486.USD","LU0251143029.SGD","SG9999005177.SGD","BK4085","LU2125910849.SGD","LU0175139822.USD","LU0441851309.USD","LU0532188223.SGD","LU2543165471.USD","FDNI","BK4581","SG9999002620.SGD","LU0345775950.USD","BK4554","LU2360107671.USD","IE0034224299.USD","LU0048573645.USD","LU0499858602.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672629967","title":"Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2672629967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672629967?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:37","pubTimestamp":1790887025,"startTime":"0","endTime":"0","summary":"The latest update is out from Nanobiotix ( ($FR:NANO) ). Nanobiotix is a late‑stage French biotechnology company developing physics‑based therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","XT","AGNG","FWD","NVIB","SYNB","BK4585","IEIH","JDOC","NANO","XBIX","FHLC","IBB","BBP","LNGR","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672761479","title":"Mizuho biotech analysts hold an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672761479","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672761479?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:00","pubTimestamp":1790881217,"startTime":"0","endTime":"0","summary":"Biotech AnaLyst Syed, along with the Biotech Research Team, discuss Vaxcyte (PCVX), ahead of VAX-31 Ph3 OPUS-1 readout this October, as well as BBI...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mizuho-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mizuho-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XBI","XBIX","LU0053671581.USD","BK4588","IE0009354923.USD","BK4581","NVIB","PCVX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672662237","title":"JPMorgan SMid biotech analysts hold an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672662237","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672662237?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:50","pubTimestamp":1790873411,"startTime":"0","endTime":"0","summary":"SMid Biotechnology Analysts Cheng and Medeiros discuss their view on Kymera Therapeutics’s (KYMR) STATS readout in atopic dermatitis on an Analyst/...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jpmorgan-smid-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jpmorgan-smid-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FNCL","JPO","IE00BFXG1179.USD","IXG","FTXO","TFNS","LU1244550577.SGD","LU2505996509.AUD","PGF","LU0211326755.USD","LU2236285917.USD","BK4207","LU2054465674.USD","NVIB","IE00BJTD4V19.USD","IE00BZ1G4Q59.USD","LU2213496289.HKD","IYF","LU0943347566.SGD","LU2357627491.SGD","BK4585","JPM","XLF","LU0345769631.USD","LU0106831901.USD","VFH","LU2168564222.USD","TRUF","IYG","IE000BZT7R73.USD","LU0820562030.AUD","LU2168563687.JPY","IE00B3S45H60.SGD","KBWB","LU0320765489.SGD","SG9999002224.SGD","BK4139","LU0234572021.USD","LU1064131342.USD","LU0265550946.USD","LU2552382132.HKD","JPMO","LU0256863902.USD","LU1917777945.USD","LU0971096721.USD","KYMR","IE00BN8TJ469.HKD","LU0238689110.USD","UYG","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672739201","title":"RYUK-IL C&S pivots to biotech and pet markets with sweeping charter changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2672739201","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672739201?lang=en_us&edition=fundamental","pubTime":"2026-10-01 11:12","pubTimestamp":1790824358,"startTime":"0","endTime":"0","summary":"RYUK-IL C&S., Ltd. ( ($KR:191410) ) has provided an announcement. RYUK-IL C&S., Ltd. shareholders approved a partial amendment of the Articles of I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ryuk-il-cs-pivots-to-biotech-and-pet-markets-with-sweeping-charter-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ryuk-il-cs-pivots-to-biotech-and-pet-markets-with-sweeping-charter-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206085","title":"Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206085?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:15","pubTimestamp":1790766915,"startTime":"0","endTime":"0","summary":"Citigroup downgraded Moderna, Inc. ($MRNA) from Neutral/High Risk to Sell/High Risk after the biotech stock’s sharp two-month rally, arguing that o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/citi-downgrades-moderna-stock-after-222-rally-calls-oncology-expectations-unrealistic?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/citi-downgrades-moderna-stock-after-222-rally-calls-oncology-expectations-unrealistic?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","XBIX","LGHT","IDNA","GNOM","BK4568","MRNY","BK4139","BK4501","BK4585","WDNA","NVIB","BK4551","MRNX","BK4532","BK4548","MRNA","BK4588","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672738443","title":"3 Australian Biotech Stocks With Up To 77% Fair Value Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2672738443","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672738443?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:20","pubTimestamp":1790763656,"startTime":"0","endTime":"0","summary":"Australia’s inflation rate sitting at 4% and interest rates at a 15 year high of 4.6% are squeezing many growth stories. Yet that pressure also pushes investors toward companies with solid balance sheets and clear funding runways. That matters for Australian biotechnology stocks, where capital access can make or break a breakthrough. This article highlights three listed biotech opportunities screened for financial resilience and reasonable value.\nThe three biotech stocks covered below are a...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-vls/vita-life-sciences-shares/news/3-australian-biotech-stocks-with-up-to-77-fair-value-upside","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-vls/vita-life-sciences-shares/news/3-australian-biotech-stocks-with-up-to-77-fair-value-upside","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IIGF.AU","GIVE.AU","BK4581","STW.AU","XBI","GEAR.AU","XKO.AU","XBIX","XJO.AU","QFN.AU","BEAR.AU","QRE.AU","VAS.AU","ZYAU.AU","BK7096","IISV.AU","BK7508","BBOZ.AU","VAP.AU","IOZ.AU","CUV.AU","IMLC.AU","BK4585","OZF.AU","NVIB","DACE.AU","EIGA.AU","E200.AU","VLS.AU","OZR.AU","BK7067","XAO.AU","MYX.AU","SLF.AU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671117244","title":"New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2671117244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671117244?lang=en_us&edition=fundamental","pubTime":"2026-09-30 02:43","pubTimestamp":1790707417,"startTime":"0","endTime":"0","summary":"How hot are biotech stocks? One of the bellwethers for the industry, the iShares Biotechnology ETF ($IBB) (left chart), has gained over 24% year to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/new-grades-price-targets-for-the-top-3-stocks-in-the-markets-hottest-sector?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/new-grades-price-targets-for-the-top-3-stocks-in-the-markets-hottest-sector?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIS","XBIX","FDN","RXL","BK4550","BIOY","IBB","PTH","BK4588","XLK","JHMH","NVIB","BK4585","FXH","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671116862","title":"Invivyd Phase 3 COVID Antibody Trial Shows Superior Safety","url":"https://stock-news.laohu8.com/highlight/detail?id=2671116862","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671116862?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:49","pubTimestamp":1790682559,"startTime":"0","endTime":"0","summary":"The latest update is out from Invivyd ( ($IVVD) ). Invivyd, Inc. is a clinical-stage biotech company developing antiviral monoclonal antibodies, le...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/invivyd-phase-3-covid-antibody-trial-shows-superior-safety?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/invivyd-phase-3-covid-antibody-trial-shows-superior-safety?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670553422","title":"GT Biopharma Regains Nasdaq Minimum Bid Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2670553422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670553422?lang=en_us&edition=fundamental","pubTime":"2026-09-26 04:54","pubTimestamp":1790369640,"startTime":"0","endTime":"0","summary":"GT Biopharma ( ($GTBP) ) has provided an announcement. GT Biopharma, Inc., a Nasdaq-listed biotech company, had fallen out of compliance with the e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gt-biopharma-regains-nasdaq-minimum-bid-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gt-biopharma-regains-nasdaq-minimum-bid-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","GT","BK4588","NQmain","BK4585","XBIX","LCLG","BK4119"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669110098","title":"VOOLT boosts deeptech portfolio with discounted stake in cancer vaccine developer Vaxican","url":"https://stock-news.laohu8.com/highlight/detail?id=2669110098","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669110098?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:47","pubTimestamp":1790160467,"startTime":"0","endTime":"0","summary":"An announcement from VOOLT Spolka Akcyjna ( ($PL:VLT) ) is now available. VOOLT S.A. has increased its stake in Polish biotech spin-off Vaxican sp....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/voolt-boosts-deeptech-portfolio-with-discounted-stake-in-cancer-vaccine-developer-vaxican?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/voolt-boosts-deeptech-portfolio-with-discounted-stake-in-cancer-vaccine-developer-vaxican?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","VLT","XBIX","EVNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669556124","title":"Arterra Bioscience Secures €2 Million Backing for NEX-BIO Biotech Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2669556124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669556124?lang=en_us&edition=fundamental","pubTime":"2026-09-23 03:02","pubTimestamp":1790103749,"startTime":"0","endTime":"0","summary":"The latest update is out from Arterra Bioscience SpA ( ($IT:ARBS) ). Arterra Bioscience S.p.A., a Naples-based green biotech group listed on Eurone...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arterra-bioscience-secures-e2-million-backing-for-nex-bio-biotech-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arterra-bioscience-secures-e2-million-backing-for-nex-bio-biotech-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","BK4139","BK4588","BK4585","XBIX","IOBT","BK4581","XBI","VGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669314478","title":"Enlivex Drops RAIN-Token Financing Deal, Halts Planned Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669314478","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669314478?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:27","pubTimestamp":1790080047,"startTime":"0","endTime":"0","summary":"An announcement from Enlivex ( ($ENLV) ) is now available. Enlivex Ltd., a Nasdaq-listed longevity-focused biotech, is developing Allocetra™, an ad...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/enlivex-drops-rain-token-financing-deal-halts-planned-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/enlivex-drops-rain-token-financing-deal-halts-planned-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB","LCLG","NQmain"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":72,"code":"91000000","status":"200"}]}}